Copyright
©The Author(s) 2023.
World J Diabetes. Apr 15, 2023; 14(4): 435-446
Published online Apr 15, 2023. doi: 10.4239/wjd.v14.i4.435
Published online Apr 15, 2023. doi: 10.4239/wjd.v14.i4.435
Variable | True positives, n, % | False positives, n, % | False negatives, n, % | True negatives, n, % | Sensitivity | Specificity | Optimal cut-off point |
A1 | 28/35 | 0/0 | 42/52.5 | 10/12.5 | 0.400 | 1.000 | 3 |
B1 | 57/71.25 | 3/3.75 | 13/16.25 | 7/8.75 | 0.814 | 0.700 | 2 |
A2 | 23/28.75 | 1/1.25 | 47/58.75 | 9/11.25 | 0.329 | 0.900 | 3 |
B2 | 59/73.75 | 4/5 | 11/13.75 | 6/7.5 | 0.843 | 0.600 | 2 |
- Citation: Sutkowska E, Marciniak D, Koszewicz M, Dziadkowiak E, Budrewicz S, Biernat K, Kuciel N, Mazurek J, Hap K. Validity and reliability of the Polish version of the Michigan Neuropathy Screening Instrument. World J Diabetes 2023; 14(4): 435-446
- URL: https://www.wjgnet.com/1948-9358/full/v14/i4/435.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i4.435